Bart N. Lambrecht

Bart N. Lambrecht studied medicine (MD, 1993) and obtained a PhD in Immunology (1999) at Ghent University, and subsequently specialized in Pulmonary Medicine at ErasmusMC in The Netherlands and University of Sydney. He became professor of Pulmonary Medicine at ErasmusMC in 2005, and returned to Belgium in 2007 as Professor of Pulmonary Medicine at Ghent University. In 2012 he became the Director of the VIB-UGent Center for Inflammation Research, one of the departments of the Flanders Institute of Biotechnology that employs more than 350 scientists working on inflammation research, at the interface of academia and industry. His own research group studies the immunological basis of asthma and respiratory viral infections, and he has published some 400 articles and book chapters on this topic. He received numerous prizes, including the Pharmacia Allergy Research Foundation Prize (2008), Franqui Prize (2014), the ERS Asthma Gold Medal (2016) and the FWO Excellence Prize Fundamental Biomedical Sciences (2020). In 2020 he coördinated 3 clinical trials on the use of immunomodulatory drugs in the treatment of COVID-19, in total enrolling more than 500 patients. His current work for which he received an ERC Advanced Grant involves the role of protein crystals in type 2 immunity in asthma and chronic rhinosinusitis.